AFR vs Chad: Meningococcal A conjugate (MENGA) vaccine immunization coverage (%)
AFR
27.0%
in 2025
Chad
65.0%
in 2025
AFR rank
5th
Chad rank
8th
Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) over time
- AFR
- Chad
How they compare
Chad currently reports 65.0% against 27.0% in AFR, a difference of 38.0%.
That makes Chad's figure about 2.4 times AFR's.
The two have swapped places 2 times across 10 shared years of data; in 2016 it was Chad ahead.
AFR ranks 5th and Chad ranks 8th of 7 groups.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | AFR | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 8.8% | 18.5% | 9.8% | Chad |
| 2020s | 25.7% | 55.5% | 29.8% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher meningococcal a conjugate (menga) vaccine immunization coverage (%), AFR or Chad?
- Chad, at 65.0% against 27.0% in AFR as of 2025.
- What is the difference in meningococcal a conjugate (menga) vaccine immunization coverage (%) between AFR and Chad?
- 38.0%, with Chad ahead.
- How many years of comparable data are there for AFR and Chad?
- 10 years are reported by both, from 2016 to 2025.
- How do AFR and Chad rank globally for meningococcal a conjugate (menga) vaccine immunization coverage (%)?
- AFR ranks 5th and Chad ranks 8th of 7 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.